In this study, we uncovered a novel mechanism by which miR-4259 is transcribed by FOXO3a and suppresses LDHA expression to inhibit the gemcitabine resistance and CSC properties of pancreatic cancer. The gene discussed is FOXO3; the disease is pancreatic neoplasm.